| Name | Title | Contact Details |
|---|
Audiology Management Group, Inc. is an innovative practice development services company geared toward helping audiology and ENT practices throughout the country thrive and grow in today`s market.
Panbio is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NovaMed Corporation is a Trumbull, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company`s SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.
Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.